Foundayo vs Wegovy Pill: Comparing Your Oral GLP-1 Options in 2026

For the first time, people looking to lose weight with a GLP-1 medication can choose between two FDA-approved pills: Novo Nordisk’s Wegovy Pill (oral semaglutide 25 mg, approved January 2026) and Eli Lilly’s Foundayo (orforglipron, approved April 2026). No more injections required.

But which one is actually better for you? The answer depends on your lifestyle, your weight loss goals, and how much flexibility you need from your medication. This guide compares everything — mechanism, dosing, food restrictions, efficacy, pricing, and side effects — so you can have an informed conversation with your provider.

How They Work: Same Target, Different Molecules

Both Foundayo and Wegovy Pill target the GLP-1 receptor, mimicking a natural hormone that regulates appetite and blood sugar. They both slow gastric emptying, reduce hunger signals in the brain, and improve insulin sensitivity. But the molecules behind them are fundamentally different.

Wegovy Pill (Oral Semaglutide)

Semaglutide is a peptide — a modified version of the natural GLP-1 hormone. It’s the same active ingredient found in injectable Wegovy and Ozempic, reformulated for oral delivery at a higher dose (25 mg). Because peptides are fragile and easily broken down by stomach acid, the tablet uses an absorption enhancer called SNAC (sodium N-[8-(2-hydroxybenzoyl)amino]caprylate) that protects the molecule and helps it cross the stomach lining.

This is why the Wegovy Pill comes with strict dosing rules: it must be taken on an empty stomach with no more than 4 ounces of plain water, and you need to wait at least 30 minutes before eating, drinking, or taking other medications.

Foundayo (Orforglipron)

Orforglipron is a small molecule — not a peptide. This is the key innovation. Because it’s a non-peptide compound, it doesn’t get destroyed by stomach acid the way semaglutide does. It doesn’t need an absorption enhancer or an empty stomach to work.

The result: Foundayo can be taken at any time of day, with or without food, and with no water restrictions. It’s the first oral GLP-1 agonist that works like a regular pill.

Dosing: Daily for Both, but Very Different Routines

Both medications are taken once daily, but the daily experience is quite different.

Wegovy Pill Dosing

Wegovy Pill follows a gradual dose escalation over several months:

Weeks 1-4: 3 mg daily
Weeks 5-8: 7 mg daily
Weeks 9-12: 14 mg daily
Week 13 onward: 25 mg daily (maintenance dose)

Each dose must be taken first thing in the morning on an empty stomach. You swallow the tablet whole with a small sip of water (4 oz or less), then wait at least 30 minutes before eating breakfast, drinking coffee, or taking any other medications. For many people, this means restructuring their morning routine around the pill.

Foundayo Dosing

Foundayo also uses dose escalation, but with more steps and more flexibility:

Weeks 1-2: 0.8 mg daily
Weeks 3-4: 1.7 mg daily
Weeks 5-6: 3.4 mg daily
Weeks 7-8: 6.9 mg daily
Week 9 onward: 12 mg or 17.2 mg daily (maintenance dose, provider decides)

The key advantage: take it whenever you want. Morning, evening, with meals, without meals — it doesn’t matter. There are no food restrictions and no waiting periods.

The Practical Difference

This may seem like a small detail, but in practice the dosing flexibility of Foundayo is a significant quality-of-life advantage. The Wegovy Pill’s empty-stomach requirement can interfere with morning medications (like thyroid drugs or blood pressure pills that also need to be taken on an empty stomach), coffee routines, and early-morning schedules. Foundayo eliminates all of those friction points.

Efficacy: How Much Weight Will You Lose?

Both medications produce clinically meaningful weight loss, but the numbers are different.

Wegovy Pill Results

In the OASIS clinical trial program, oral semaglutide 25 mg showed:

~15% total body weight loss over 68 weeks
Statistically significant improvements in waist circumference, blood pressure, and cholesterol
Results roughly comparable to injectable Wegovy (semaglutide 2.4 mg), which showed ~15-17% weight loss in the STEP trials

For a 220-pound person, 15% weight loss translates to about 33 pounds.

Foundayo Results

In the ATTAIN clinical trial program, orforglipron showed:

~12% total body weight loss at the 12 mg dose over 72 weeks
Slightly higher results at the 17.2 mg maintenance dose (closer to 13-14% in some analyses)
Meaningful improvements in metabolic markers including HbA1c, blood pressure, and triglycerides

For a 220-pound person, 12% weight loss translates to about 26 pounds.

The Bottom Line on Efficacy

Wegovy Pill has a clear edge on raw weight loss numbers — roughly 15% vs 12%. That 3-percentage-point gap translates to about 7 pounds for a 220-pound person over the course of treatment. Whether that difference is meaningful to you depends on your goals and how you weigh efficacy against the convenience factors below.

It’s also worth noting that individual results vary significantly. Some people on Foundayo lose more than the average Wegovy Pill user, and vice versa. The averages tell a population-level story, not your personal story.

Pricing: Surprisingly Similar

Both manufacturers have adopted aggressive self-pay pricing strategies, making these pills more affordable than the injectable GLP-1 medications at retail prices.

Wegovy Pill Pricing

List price: ~$850/month
NovoCare self-pay: $149-299/month (depending on dose)
With commercial insurance + savings card: as low as $25/month
Costco partnership: approximately $499/month

Foundayo Pricing

List price: ~$800/month
LillyDirect self-pay: $149-299/month (depending on dose)
With commercial insurance + savings card: as low as $25/month

Price Comparison

At the self-pay level, Foundayo and Wegovy Pill are priced almost identically — both in the $149-299/month range through their respective manufacturer programs. If you have commercial insurance, both can drop to $25/month with a savings card.

The real price differences may come down to your specific insurance formulary. Some plans cover Novo Nordisk products but not Lilly products, and vice versa. Use our price comparison tool to check the latest prices across all providers and find the best deal for your situation.

Side Effects: A Similar Profile with Small Differences

Both medications share the common GLP-1 side effect profile, primarily gastrointestinal symptoms that tend to be worst during dose escalation and improve over time.

Common Side Effects (Both Medications)

Nausea — the most frequently reported side effect for both
Diarrhea
Vomiting
Constipation
Abdominal pain
Decreased appetite (sometimes listed as a side effect, though most patients consider it the point)

Differences Worth Noting

Wegovy Pill may cause more GI symptoms early in treatment because oral semaglutide at the 25 mg dose delivers a substantial amount of the active drug directly to the stomach lining. Some patients report more intense nausea during the first few weeks compared to the injectable form.

Foundayo had a slightly lower rate of nausea in clinical trials compared to oral semaglutide, though the difference was modest. Its more gradual five-step dose escalation (vs. Wegovy Pill’s four steps) may contribute to better tolerability for some patients.

Both medications carry warnings about the potential for pancreatitis, thyroid C-cell tumors (based on animal studies), and gallbladder problems. These risks are considered class-wide for GLP-1 agonists.

Discontinuation Rates

In clinical trials, about 6-8% of participants on Foundayo and 7-10% on Wegovy Pill discontinued due to side effects. These rates are relatively similar and in line with other GLP-1 medications.

Availability: Who Can Get What?

Wegovy Pill

Wegovy Pill has been available since January 2026 and has had several months to ramp up supply. It’s available at most retail pharmacies and through NovoCare’s direct program. Supply has been generally stable, though some pharmacies and dose strengths may experience periodic shortages.

Foundayo

Foundayo received FDA approval in April 2026 and is in its initial launch phase. Eli Lilly is distributing primarily through LillyDirect and select retail pharmacies. Availability is expanding but may be more limited in some areas during the first few months. Lilly has indicated they built up significant inventory pre-launch, so widespread shortages are not expected.

How to Choose: A Decision Framework

Here’s a straightforward framework for deciding between Foundayo and Wegovy Pill:

Choose Wegovy Pill if:

Maximum weight loss is your top priority. The ~15% average weight loss is higher than Foundayo’s ~12%.
You’re already on semaglutide (Ozempic, Rybelsus, injectable Wegovy) and want to switch to a pill form of the same molecule you know works for you.
The empty-stomach requirement doesn’t bother you. If you already take medication first thing in the morning and can work around the 30-minute waiting period, this may be a non-issue.
Your insurance covers Novo Nordisk products but not Eli Lilly products.

Choose Foundayo if:

Convenience and flexibility matter most. No food restrictions, no water restrictions, take it any time of day.
You take other morning medications that also require an empty stomach (like levothyroxine) and don’t want to juggle timing.
You tried oral semaglutide and had trouble with the dosing requirements or experienced significant GI side effects early on.
Your insurance covers Eli Lilly products but not Novo Nordisk products.
You want the newest science. Foundayo is the first non-peptide oral GLP-1 — a genuinely novel class of molecule.

Either Could Work if:

You’re new to GLP-1 medications and don’t have a strong preference.
Your insurance covers both.
You’re paying self-pay through manufacturer programs (the prices are nearly identical).

The Bigger Picture

Having two oral GLP-1 options competing head-to-head is great for patients. It drives prices down, pushes both companies to improve their products, and gives providers more flexibility to match treatments to individual patients.

If you’re comparing prices between Foundayo, Wegovy Pill, and the injectable options, use our price comparison tool to see the latest pricing across all medications, dosages, and providers in one place.

The best oral GLP-1 is the one you’ll actually take consistently. For some people, that means the one with the highest efficacy. For others, it means the one that fits seamlessly into their daily life. Talk to your provider about which factors matter most for your situation.

This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or changing any medication. Individual results vary, and the information above reflects clinical trial averages and pricing available at the time of publication.